Steven Cohen Abbott Laboratories Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Abbott Laboratories stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 4,500 shares of ABT stock, worth $605,655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,500
Previous 36,300
87.6%
Holding current value
$605,655
Previous $4.82 Million
87.29%
% of portfolio
0.0%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding ABT
# of Institutions
3,600Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$23.3 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.5 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$8.09 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.62 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $236B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...